Skip to main content

Table 2 Overall survival according to the chemotherapy regimen

From: Safety and efficacy of cytotoxic chemotherapy in hepatocellular carcinoma after first-line treatment with sorafenib

Chemotherapy regimen

N

Median months

95%CI months

Doxorubicin

25

8.05

2.33-10.22

mFLOX/CapOx

09

8.57

0.62-NA

GemOx

02

3.51

3.51-NA

Capecitabine plus IFN

01

NA

NA

5-Fluorouracil

08

2.73

0.36-NA

Total

45

8.05

2.73-9.89

  1. 95%CI: 95% confidence interval; mFLOX: modified 5-fluorouracil and oxaliplatin combination; CapOx: capecitabine and oxaliplatin combination; gencitabibe and oxaliplatin combination; IFN: interferon.